Submitted by Anonymous (not verified) on 27 January 2026 - 15:24
Human medicines European public assessment report (EPAR): Ozempic, semaglutide, Date of authorisation: 08/02/2018, Revision: 19, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Ozempic, semaglutide, Date of authorisation: 08/02/2018, Revision: 19, Status: Authorised